339 related articles for article (PubMed ID: 9864972)
1. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
2. Best-buy regimen of ursodeoxycholic acid for patients with gallstones.
Lanzini A; Facchinetti D; Pigozzi MG; Bettini L; Muiesan G
Scand J Gastroenterol; 1991 May; 26(5):551-6. PubMed ID: 1871547
[TBL] [Abstract][Full Text] [Related]
3. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
4. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
5. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
6. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
7. [Per oral gallstone dissolution therapy].
Sugata F
Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
[TBL] [Abstract][Full Text] [Related]
8. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
9. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy.
Sackmann M; Koelbl R; Pauletzki J; Cremer P; Klueppelberg UG; von Ritter C; Sauter G; Holl J; Seidel D; Paumgartner G
Z Gastroenterol; 1995 Oct; 33(10):585-9. PubMed ID: 7502550
[TBL] [Abstract][Full Text] [Related]
12. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
14. Routine determination of biliary lipid composition with the entero-test.
Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
[TBL] [Abstract][Full Text] [Related]
15. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial.
Hyun JJ; Lee HS; Kim CD; Dong SH; Lee SO; Ryu JK; Lee DH; Jeong S; Kim TN; Lee J; Koh DH; Park ET; Lee IS; Yoo BM; Kim JH
Gut Liver; 2015 Jul; 9(4):547-55. PubMed ID: 26087862
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
18. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis].
Di Mario F; Angonese C; Del Favero G; Aggio L; Meggiato T; Scalon P; Basso D; Plebani M; Burlina A; Naccarato R
G Clin Med; 1990; 71(6-7):435-41. PubMed ID: 2258026
[TBL] [Abstract][Full Text] [Related]
20. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
